Tomaszewska-Zaremba Dorota, Gajewska Alina, Misztal Tomasz
Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jablonna, Poland.
Int J Mol Sci. 2025 Jul 8;26(14):6570. doi: 10.3390/ijms26146570.
Many neurodegenerative diseases are associated with immune system disorders, while neurodegenerative processes often occur in inflammatory conditions of the Central Nervous System (CNS). Cannabinoids exhibit significant therapeutic potential due to their dual ability to modulate both neural and immune functions. These compounds have a broad spectrum of action, allowing them to target multiple pathological mechanisms underlying neurodegenerative and inflammatory CNS diseases. The present review outlines the therapeutic potential of cannabinoids, with a focus on their anti-inflammatory properties, in the treatment of neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease, as well as inflammatory CNS disorders like multiple sclerosis and HIV-associated dementia.
许多神经退行性疾病都与免疫系统紊乱有关,而神经退行性过程往往发生在中枢神经系统(CNS)的炎症状态下。大麻素具有调节神经和免疫功能的双重能力,因此具有显著的治疗潜力。这些化合物具有广泛的作用谱,使其能够针对神经退行性和炎症性中枢神经系统疾病的多种病理机制。本综述概述了大麻素在治疗神经退行性疾病(包括阿尔茨海默病、帕金森病、肌萎缩侧索硬化症和亨廷顿舞蹈症)以及炎症性中枢神经系统疾病(如多发性硬化症和HIV相关痴呆症)方面的治疗潜力,重点关注其抗炎特性。